Paper17519122
Compliance and fixed-dose combination therapy.
Bangalore S and 3 others. Curr Hypertens Rep, 2007. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Compliance and fixed-dose combination therapy. Papers, record 17519122. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519122
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Patient Compliance | Major topic |
| Blood Pressure | |
| Cost-Benefit Analysis | |
| Dose-Response Relationship, Drug | |
| Drug Combinations | |
| Humans | |
| Risk Factors | |
| Treatment Refusal |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16870079 | Overcoming barriers to effective blood pressure control in patients with hypertension. | Curr Med Res Opin | 2006 | https://conductscience.org/library/papers/16870079 | PubMed |
| 2 | 11465916 | Achieving blood pressure targets in the management of hypertension. | Blood Press Suppl | 2001 | https://conductscience.org/library/papers/11465916 | PubMed |
| 3 | 15076203 | Foot volume increase on nifedipine is not prevented by pretreatment with diuretics. | J Hypertens | 2004 | https://conductscience.org/library/papers/15076203 | PubMed |
| 4 | 15652604 | Global burden of hypertension: analysis of worldwide data. | Lancet | 2005 | https://conductscience.org/library/papers/15652604 | PubMed |
| 5 | 16494640 | Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter? | Int J Clin Pract | 2006 | https://conductscience.org/library/papers/16494640 | PubMed |
| 6 | 12441226 | Pedal edema--not all dihydropyridine calcium antagonists are created equal. | Am J Hypertens | 2002 | https://conductscience.org/library/papers/12441226 | PubMed |
| 7 | 12556541 | Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12556541 | PubMed |
| 8 | 9518949 | Managing the patient with hard-to-control hypertension. | Am Fam Physician | 1998 | https://conductscience.org/library/papers/9518949 | PubMed |
| 9 | 12748199 | The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | JAMA | 2003 | https://conductscience.org/library/papers/12748199 | PubMed |
| 10 | 12829553 | A strategy to reduce cardiovascular disease by more than 80%. | BMJ | 2003 | https://conductscience.org/library/papers/12829553 | PubMed |
| 11 | 11952029 | Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. | Clin Ther | 2002 | https://conductscience.org/library/papers/11952029 | PubMed |
| 12 | 1728930 | Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. | Arch Intern Med | 1992 | https://conductscience.org/library/papers/1728930 | PubMed |
| 13 | 11713851 | The multifactorial nature of hypertension: the greatest challenge for its treatment? | J Hypertens Suppl | 2001 | https://conductscience.org/library/papers/11713851 | PubMed |
| 14 | 12418941 | Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. | Arch Intern Med | 2002 | https://conductscience.org/library/papers/12418941 | PubMed |
| 15 | 15631534 | Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide. | Am J Cardiovasc Drugs | 2005 | https://conductscience.org/library/papers/15631534 | PubMed |
| 16 | 15908846 | Impact of medication adherence on hospitalization risk and healthcare cost. | Med Care | 2005 | https://conductscience.org/library/papers/15908846 | PubMed |
| 17 | 9635947 | Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. | Lancet | 1998 | https://conductscience.org/library/papers/9635947 | PubMed |
| 18 | 16470077 | Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. | J Clin Hypertens (Greenwich) | 2006 | https://conductscience.org/library/papers/16470077 | PubMed |
| 19 | 11827559 | Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. | Drugs | 2002 | https://conductscience.org/library/papers/11827559 | PubMed |
| 20 | 14564133 | Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. | J Clin Hypertens (Greenwich) | 2003 | https://conductscience.org/library/papers/14564133 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41504880 | Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41504880 | PubMed |
| 38319595 | Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial. | J Clin Hypertens (Greenwich) | 2024 | https://conductscience.org/library/papers/38319595 | PubMed |
| 36843692 | Effect of the Polypill on Adherence and Prevention of Cardiovascular Diseases in Patients With or at High Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. | Cureus | 2023 | https://conductscience.org/library/papers/36843692 | PubMed |
| 34575448 | 3D Printing of Pharmaceutical Application: Drug Screening and Drug Delivery. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575448 | PubMed |
| 34504874 | Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34504874 | PubMed |
| 32098393 | Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32098393 | PubMed |
| 30582181 | Development of an entirely remote, non-physician led hypertension management program. | Clin Cardiol | 2019 | https://conductscience.org/library/papers/30582181 | PubMed |
| 30568434 | Factors influencing adherence to treatment in older adults with hypertension. | Clin Interv Aging | 2018 | https://conductscience.org/library/papers/30568434 | PubMed |
| 29081008 | Hypertension in African Americans. | Curr Cardiol Rep | 2017 | https://conductscience.org/library/papers/29081008 | PubMed |
| 28608025 | Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control. | High Blood Press Cardiovasc Prev | 2017 | https://conductscience.org/library/papers/28608025 | PubMed |
| 28166827 | The polypill approach - An innovative strategy to improve cardiovascular health in Europe. | BMC Pharmacol Toxicol | 2017 | https://conductscience.org/library/papers/28166827 | PubMed |
| 27891352 | Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country. | J Clin Diagn Res | 2016 | https://conductscience.org/library/papers/27891352 | PubMed |
| 27536448 | Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study. | J Drug Assess | 2014 | https://conductscience.org/library/papers/27536448 | PubMed |
| 25525383 | Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland. | Int J Gen Med | 2014 | https://conductscience.org/library/papers/25525383 | PubMed |
| 24985411 | Efficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study. | Adv Ther | 2014 | https://conductscience.org/library/papers/24985411 | PubMed |
| 24136760 | Factors that interfere the medication compliance in hypertensive patients. | Einstein (Sao Paulo) | 2013 | https://conductscience.org/library/papers/24136760 | PubMed |
| 23630412 | Phentermine and topiramate for the management of obesity: a review. | Drug Des Devel Ther | 2013 | https://conductscience.org/library/papers/23630412 | PubMed |
| 21949631 | Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination. | Integr Blood Press Control | 2010 | https://conductscience.org/library/papers/21949631 | PubMed |
| 19499963 | Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study. | Clin Drug Investig | 2009 | https://conductscience.org/library/papers/19499963 | PubMed |
| 18691228 | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. | Int J Clin Pract | 2008 | https://conductscience.org/library/papers/18691228 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17519122
GET https://conductscience.org/api/papers/v1/17519122/references?page=2